OSAKA Study Results Met Primary Endpoint And Show That Both ADVAGRAF(R) And PROGRAF(TM) Give Similar Results In Renal Transplantation
Links shared publicly online about this topic.
- 321total visits
OSAKA Study Results Met Primary Endpoint And Show That Both ADVAGRAF(R) And PROGRAF(TM) Give Similar Results In Renal Transplantation
Astellas Pharma Europe Ltd today announced that the results of the 6-month OSAKA study demonstrate that tacrolimus prolonged release (QD; ADVAGRAF(R), Graceptor(R) in Japan)-based therapy is non
View full resource at medicalnewstoday.com
Tags: Kidney Health, Urinary System, Organ Transplant Rejection Medication, Pharma, Prograf, Astellas Pharma, Transplantation
Most Recently Shared on May 3, 2011 at 8:05 am By:
OSAKA Study Results Met Primary Endpoint And Show That Both ADVAGRAF(R) And PROGRAF(TM) Give Similar Results In Renal ... http://mnt.to/3Vhv
Also Shared By:
Advertisement
MNT Urology
@mnt_urology
OSAKA Study Results Met Primary Endpoint And Show That Both ADVAGRAF(R) And PROGRAF(TM) Give Similar Results In Renal ... http://mnt.to/3Vhv
1 year ago...